Neurofeedback in Alcohol and Drug Dependency

Introduction to Quantitative EEG and Neurofeedback

Volumn , Issue , 2009, Pages 239-267

  Trudeau, David L ^a   Sokhadze, Tato M ^b   Cannon, Rex L ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882556239     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374534-7.00010-1     Document Type: Chapter

References (156)

1. Alper K.R. The EEG and cocaine sensitization. Journal of Neuropsychiatry and Clinical Neuroscience 1999, 11:209-221.
2. Alper K.R., Chabot R.J., Kim A.H., Prichep L.S., John E.R. Quantitative EEG correlates of crack cocaine dependence. Psychiatry Research 1990, 35:95-106.
3. Alper K.R., Prichep L.S., Kowalik S., Rosenthal M.S., John E.R. Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 1998, 19:1-9.
4. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, Fourth edition [DSM-IV], Text revised, Washington, DC.
5. Bauer L.O. Frontal P300 decrement, childhood conduct disorder, family history, and predisposition of relapse among abstinent cocaine abusers. Drug & Alcohol Dependence 1997, 44:1-10.
6. Bauer L.O. Predicting relapse to alcohol and drug abuse via quantitative electroencephalography. Neuropsychopharmacology 2001, 25:332-333.
7. Bauer L.O. CNS recovery from cocaine, cocaine and alcohol, or opioid dependence: a P300 study. Clinical Neurophysiology 2001, 112(8):1508-1515.
8. Bauer L.O. Differential effects of alcohol, cocaine, and opiod abuse on event-related potentials recorded during a response competition task. Drug and Alcohol Dependence 2002, 66:137-145.
9. Bauer L.O., Hesselbrock V. CSD/BEM localization of P300 sources in adolescents "at risk": Evidence of frontal cortex dysfunction in conduct disorder. Biological Psychiatry 2001, 50:600-608.
10. Bauer L.O., Hesselbrock V.M. Lateral asymmetries in the frontal brain: effects of depression and a family history of alcoholism in female adolescents. Alcoholism Clinical and Experimental Research 2002, 26:1662-1668.
11. Biederman J., Wilens T., Mick E., Milberger S., Spencer T.J., Farone S.V. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry 1995, 152(11):1652-1658.
12. Biggins C.A., MacKay S., Clark W., Fein G. Event-related potential evidence for frontal cortex effects of chronic cocaine dependence. Biological Psychiatry 1997, 42:472-485.
13. Block R.I., O'Leary D.S., Hichwa R.D., et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacology, Biochemistry and Behavior 2002, 72:237-250.
14. Bodenhamer-Davis E., Callaway T. Extended follow-up of Peniston Protocol results with chemical dependency. Journal of Neurotherapy 2004, 8(2):135.
15. Breslau N., Davis G.C., Andreski P., Peterson E. Traumatic events and post traumatic stress disorder in an urban population of young adults. Archives of General Psychiatry 1991, 48:216-222.
16. Brinkman D.N. Biofeedback application to drug addiction in the University of Colorado drug rehabilitation program. International Journal of Addiction 1978, 13(5):817-830.
17. Brown P.J., Recupero P.R., Stout R. PTSD-substance abuse comorbidity and treatment utilization. Addictive Behavior 1995, 20:251-254.
18. Burkett, S. V., Cummins, J. M., Dickson, R., and Skolnick, M. H. (2003). Neurofeedback in the treatment of addiction with a homeless population. Presented at ISNR 11th annual conference, Houston, TX, September 18-21.
19. Burkett S.V., Cummins J.M., Dickson R., Skolnick M.H. An open clinical trial utilizing real-time EEG operant conditioning as an adjunctive therapy in the treatment of crack cocaine dependence. Journal of Neurotherapy 2005, 9(2):27-47.
20. Cannon R., Lubar J., Gerke A., Thornton K. Topographical coherence and absolute power changes resulting from LORETA Neurofeedback in the anterior cingulate gyrus. Journal of Neurotherapy 2006, 10(1):5-31.
21. Cannon R., Lubar J., Congedo M., Thornton K., Hutchens T., Towler K. The effects of Neurofeedback in the cognitive division of the anterior cingulate gyrus. International Journal of Neuroscience 2007, 117(3):337-357.
22. Carter B.L., Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 1999, 94:327-340.
23. Unintentional and undetermined poisoning deaths-11 states, 1990-2001. Morbidity and Mortality Weekly Reports 2004, 53:233-238. CDC (Centers for Disease Control Prevention).
24. Clark D., Parker A., Lynch K. Psychopathology of substance related problems during early adolescence: a survival analysis. Journal of Clinical Child Psychology 1999, 28:333-341.
25. Cohen H.L., Ji J., Chorlian D.B., Begleiter H., Porjesz B. Alcohol-related ERP changes recorded from different modalities: a topographic analysis. Alcoholism: Clinical and Experimental Research 2002, 26:303-317.
26. Congedo, M. (2003). Tomographic Neurofeedback: A new technique for the self-regulation of brain electrical activity. An unpublished dissertation. University of Tennessee, Knoxville, 2003.
27. Congedo M., Lubar J., Joffe D. Low-resolution electromagnetic tomography neurofeedback. IEEE Transactions On Neuronal Systems and Rehabilitation Engineering 2004, 12(4):387-397.
28. Costa L., Bauer L. Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence. Drug & Alcohol Dependence 1997, 46:87-93.
29. Cottler L.B., Compton W., Mager D., Spitznagel E., Janca A. Post traumatic stress disorder among substance abusers from a general population. American Journal of Psychiatry 1992, 149:664-670.
30. Crits-Christoph P., Siqueland L., Blaine J., et al. Psychosocial treatments for cocaine dependence: National Institute On Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry 1999, 56:450-493.
31. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. Journal of Urban Health 2003, 80:189-200.
32. DeBeus R., Prinzel H., Ryder-Cook A., Allen L. QEEG-based versus research-based EEG biofeedback treatment with chemically dependent outpatients: preliminary results. Journal of Neurotherapy 2002, 6(1):64-66.
33. De Bruin E.A., Stam C.J., Bijl S., Verbaten M.N., Kenemans J.L. Moderate-to-heavy alcohol intake is associated with differences in synchronization of brain activity during rest and mental rehearsal. International Journal of Psychophysiology 2006, 60(3):304-314.
34. DeGood D.E., Valle R.S. Self-reported alcohol and nicotine use and the ability to control occipital EEG in a biofeedback situation. Addictive Behaviors 1978, (1):13-18.
35. De Lima M.S., de Oliveira Soares B.G., Reisser A.A., Farrell M. Pharmacological treatment of cocaine dependence: a systematic review. Addiction 2002, 97:931-949.
36. Denney M.R., Stelson J.L., Hardt H.D. Sobriety outcome after alcoholism treatment with biofeedback participation: A pilot inpatient study. International Journal of Addiction 1991, 26:335-341.
37. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology 1999, 375(1-3):13-30.
38. Downey K.K., Stelson F.W., Pomerleau O.F., Giordani B. Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. Journal of Nervous and Mental Diseases 1997, 185(1):32-38.
39. Drake R.E., Wallach M.A. Dual diagnosis 15 years of progress. Psychiatry Services 2000, 51:1126-1129.
40. Egerton A., Allison C., Brett R.R., Pratt J.A. Cannabinoids and prefrontal cortical function: Insights from preclinical studies. Neuroscience and Biobehavioral Reviews 2006, 30:680-695.
41. Ehlers C.L., Wall T.L., Schuckit M.A. EEG spectral characteristics following ethanol administration in young men. Electroencephalography and Clinical Neurophysiology 1989, 73:179-187.
42. Evans K., Sullivan J.M. Treating addicted survivors of trauma 1995, Guilford Press, New York.
43. Fahrion, S. L. (2002). Group biobehavioral treatment of addiction. Paper presented at The 4th Meeting on the Neurobiology of Criminal and Violent Behavior. Research and Clinical Applications of Neurofeedback for Offender Populations with Substance Use Disorders.
44. Fahrion S.L., Walters D., Coyne L., Allen T. Alterations in EEG amplitude, personality factors and brain electrical mapping after alpha-theta brainwave training: a controlled case study of an alcoholic in recovery. Alcoholism: Clinical Experimental Research 1992, 16:547-551.
45. Fein G., Biggins C., Mackay S. Cocaine abusers have reduced auditory PSO amplitude and suppression compared to both normal controls and alcoholics. Biological Psychiatry. Alcoholism: Clinical Experimental Research 1996, 39:955-965.
46. Fingelkurts A.A., Fingelkurts A.A., Kivisaari R., et al. Reorganization of the composition of brain oscillations and their temporal characteristics in opioid dependent patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006, 30(8):1453-1465.
47. Fingelkurts A.A., Fingelkurts A.A., Kivisaari R., et al. Increased local and decreased remote functional connectivity at EEG alpha and beta frequency bands in opioid-dependent patients. Psychopharmacology 2006, 188(1):42-52.
48. Finkelberg A., Sokhadze E., Lopatin A., et al. The application of alpha-theta EEG biofeedback training for psychological improvement in the process of rehabilitation of the patients with pathological addictions. Biofeedback and Self-Regulation 1996, 21:364.
49. Finn P.R., Justus A. Reduced EEG alpha power in the male and female offspring of alcoholics. Alcoholism: Clinical and Experimental Research 1999, 23(2):256-262.
50. Franken I.H.A., Stam C.J., Hendriks V.M., van den Brink W. Electroencephalographic power and coherence analysis suggest altered brain function in abstinent male heroin-dependent patients. Neuropsychobiology 2004, 49:105-110.
51. French M.T., McGeary K.A., Chitwood D.D., McCoy C.B. Chronic illicit drug use, health services utilization and the cost of medical care. Social Science and Medicine 2000, 50:1703-1713.
52. Friedman D., Squires-Wheeler E. Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophrenia Bulletin 1994, 20(1):63-74.
53. Goldberg R.J., Greenwood J.C., Taintor Z. Alpha conditioning as an adjunct treatment for drug dependence: part I. International Journal of Addiction 1976, 11(6):1085-1089.
54. Goldberg R.J., Greenwood J.C., Taintor Z. Alpha conditioning as an adjunct treatment for drug dependence: part II. International Journal of Addiction 1977, 12(1):195-204.
55. Goslinga J.J. Biofeedback for chemical problem patients: a developmental process. Journal of Biofeedback 1975, 2:17-27.
56. Grabowski J., Shearer J., Merrill J., Negus S.S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 2004, 29:1439-1464.
57. Grant B.F., Stinson F., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Archives of General Psychiatry 2004, 61:361-368.
58. Green E.E., Green A.M., Walters E.D. Alpha-theta biofeedback training. Journal of Biofeedback 1974, 2:7-13.
59. Gurnee, R. (2004). Subtypes of alcoholism and CNS depressant abuse. Presented at The Winter Brain, Optimal Functioning, and Positive Psychology Meeting. Palm Springs, 2004 http://www.brainmeeting.com/2004_abstracts.htm.
60. Hada M., Porjesz B., Begleiter H., Polich J. Auditory P3a assessment of male alcoholics. Biological Psychiatry 2000, 48:276-286.
61. Herning R.I., Jones R.T., Hooker W.D., Mendelson J., Blackwell L. Cocaine increases EEG beta: a replication and extension of Hans Berger's historic experiments. Electroencephalography and Clinical Neurophysiology 1985, 60(6):470-477.
62. Herning R.I., Glover B.J., Guo X. Effects of cocaine on P3B in cocaine abusers. Neuropsychobiology 1994, 30:132-142.
63. Herning R.I., Glover B.J., Koeppl B., Phillips R.L., London E.D. Cocaine induced increases in EEG alpha and beta activity: evidence for reduced cortical processing. Neuropsychopharmacology 1994, 11:1-9.
64. Horner B.R., Scheibe K.E. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(1):30-36.
65. Iwanami A., Suga I., Kaneko T., Sugiyama A., Nakatani Y. P300 component of event-related potentials in methamphetamine psychosis and schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 1994, 18:465-475.
66. Iwanami A., Kuroki N., Iritani S., Isono H., Okajima Y., Kamijima K. P3a of event-related potential in chronic methamphetamine dependence. Journal of Nervous and Mental Diseases 1998, 186:746-751.
67. Jacobsen L.K., Southwick S., Kosten T.R. Substance use disorders in patients with post traumatic stress disorder. American Journal of Psychiatry 2001, 158:1184-1190.
68. Jones F.W., Holmes D.S. Alcoholism, alpha production, and biofeedback. Journal of Consulting and Clinical Psychology 1976, 44(2):224-228.
69. Kaiser D.A., Othmer S. Effect of Neurofeedback on variables of attention in a large multi-center trial. Journal of Neurotherapy 2000, 4(1):5-15.
70. Kalechstein A.D., Newton T.F., Longshore D., Anglin M.D., van Gorp W.G., Gawin F.H. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences 2000, 12:480-484.
71. Kalechstein A.D., Newton T.F., Green M.F. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences 2003, 15:215-220.
72. Katayama J., Polich J. P300 from one-, two-, and three-stimulus auditory paradigms. International Journal of Psychophysiology 1996, 23:33-40.
73. Katayama J., Polich J. Stimulus context determines P3a and P3b. Psychophysiology 1998, 35:23-33.
74. Kelly M.J. Native Americans, neurofeedback, and substance abuse theory: three year outcome of alpha/theta neurofeedback training in the treatment of problem drinking among Dine' (Navajo) People. Journal of Neurotherapy 1997, 2(3):24-60.
75. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
76. Kouri E.M., Lukas S.E., Mendelson J.H. P300 assessment of opiate and cocaine abusers: effects of detoxification and bupernorphine treatment. Biological Psychiatry 1996, 40:617-628.
77. Landen M.G., Castle S., Nolte K.B. Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in New Mexico. American Journal of Epidemiology 2003, 157:273-278.
78. Lukas S.E., Mendelson J.H., Benedikt R. Electroencephalographic correlates of marihuana-induced euphoria. Drug and Alcohol Dependence 1995, 37:131-140.
79. Manuzza S., Klein R.G., Konig P.H., Giampino P.L. Hyperactive boys almost grown up, IV. Criminality and its relationship to psychiatric status. Archives of General Psychiatry 1989, 46:1073-1079.
80. Miller W., Rollnick S. Motivational Interviewing 2002, Guilford, New York.
81. Monastra V.J., Lynn S., Linden M., Lubar J.F., Gruzelier J., LaVaque T.J. Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback 2005, 30:95-114.
82. Näätänen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive functioning. Behavioral and Brain Sciences 1990, 13:201-287.
83. Newton T.F., Cook I.A., Kalechstein A.D., et al. Quantitative EEG abnormalities in recently abstinent methamphetamine-dependent individuals. Clinical Neurophysiology 2003, 114:410-415.
84. Newton T.F., Kalechstein A.D., Hardy D.J., et al. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clinical Neurophysiology 2004, 115:194-198.
85. Noldy N.E., Santos C.V., Politzer N., Blair R.D., Carlen P.L. Quantitative EEG changes in cocaine withdrawal: evidence for long-term CNS effects. Neuropsychobiology 1994, 30:189-196.
86. Nowlis D.P., Kamiya J. The control of electroencephalograhic alpha rhythms through auditory feedback and the associated mental activity. Psychophysiology 1970, 6:476-484.
87. O'Brien C.P., Charney D.S., et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biological Psychiatry 2004, 56:703-713.
88. O'Connor S., Bauer L.O., Tasman A., Hesselbrock V.M. Reduced P3 amplitudes of ERPs are associated with both a family history of alcoholism and antisocial personality disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 1994, 18:1307-1321.
89. O'Leary D.S., Block R.I., Koeppel J.A., et al. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002, 26:802-816.
90. Papageorgiou C., Liappas I., Asvestas P., et al. Abnormal P600 in heroin addicts with prolonged abstinence elicited during a working memory test. NeuroReport 2001, 12:1773-1778.
91. Papageorgiou C., Liappas I., Ventouras E.M., et al. Long-term abstinence syndrome in heroin addicts: indices of P300 alterations associated with a short memory task. Progress in Neuropsychopharmacology and Biological Psychiatry 2004, 28:1109-1115.
92. Passini F.T., Watson C.G., Dehnel L., Herder J., Watkins B. Alpha wave biofeedback training therapy in alcoholics. Journal of Clinical Psychology 1977, 33(1):292-299.
93. Patrick G., Straumanis J.J., Struve F.A., Fitz-Gerald M.J., Manno J.E. Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: a paucity of significant findings. Clinical Electroencephalography 1997, 28(1):26-31.
94. Peniston E.G., Kulkosky P.J. Alpha-theta brainwave training and beta endorphin levels in alcoholics. Alcoholism Clinical and Experimental Research 1989, 13:271-279.
95. Peniston E.G., Kulkosky P.J. Alcoholic personality and alpha-theta brainwave training. Medical Psychotherapy 1990, 2:37-55.
96. Peniston E.G., Kulkosky P.G. Alpha-theta brain wave neurofeedback for Vietnam veterans with combat related post traumatic stress disorder. Medical Psychotherapy 1991, 4:1-14.
97. Peniston E.G., Marriman D.A., Deming W.A., Kulkosky P.G. EEG alpha-theta brain wave synchronization in Vietnam theater veterans with combat related post traumatic stress disorder and alcohol abuse. Medical Advances in Medical Psychotherapy 1993, 6:37-50.
98. Polich J. P300, probability, and interstimulus interval. Psychophysiology 1990, 27:396-403.
99. Polich J., Herbst K.L. P300 as a clinical assay: Rationale, evaluation and findings. International Journal of Psychophysiology 2000, 38(1):3-19.
100. Polich J., Pollock V.E., Bloom F.E. Meta-analysis of P300 from males at risk for alcoholism. Psychological Bulletin 1994, 115(1):55-73.
101. Polunina A.G., Davydov D.M. EEG spectral power and mean frequencies in early heroin abstinence. Progress in Neuropsychopharmacology and Biological Psychiatry 2004, 28(1):73-82.
102. Porjesz B., Begleiter H. Genetic basis of event-related potentials and their relationship to alcoholism and alcohol use. Journal of Clinical Neurophysiology 1998, 15:44-57.
103. Porjesz B., Rangaswamy M., Kamarajan C., Jones K.A., Padmanabhapillai A., Begleiter H. The utility of neurophysiological markers in the study of alcoholism. Clinical Neurophysiology 2005, 116:993-1018.
104. Prichep L.S., Alper K.A., Kowalik S.C., Rosenthal M. Neurometric QEEG studies of crack cocaine dependence and treatment outcome. Journal of Addictive Disorders 1996, 15(4):39-53.
105. Prichep L.S., Alper K.R., Kowalik S.C., et al. Prediction of treatment outcome in cocaine dependent males using quantitative EEG. Drug and Alcohol Dependence 1999, 54:35-43.
106. Prichep L.S., Alper K.A., Sverdlov L., et al. Outcome related electrophysiological subtypes of cocaine dependence. Clinical Electroencephalography 2002, 33(1):8-20.
107. Pritchard W. Psychophysiology of P300. Psychological Bulletin 1981, 89:506-540.
108. Rangaswamy M., Porjesz B., Chorlian D., et al. Beta power in the EEG of alcoholics. Biological Psychiatry 2002, 52:831-842.
109. Rangaswamy M., Porjesz B., Chorlian D., et al. Resting EEG in offspring of male alcoholics: beta frequencies. International Journal of Psychophysiology 2004, 51:239-251.
110. Reid M., Flammino F., Howard B., Nilsen D., Prichep L.S. Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans. Neuropsychopharmacology 2006, 31:872-884.
111. Regier D.A., Farmer M.E., Rae D.S., et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 1990, 264:2511-2518.
112. Roemer R.A., Cornwell A., Dewart D., Jackson P., Ercegovac D.V. Quantitative electroencephalographic analysis in cocaine-preferring polysubstance abusers during abstinence. Psychiatry Research 1995, 58:247-257.
113. Rosenfeld J.P. An EEG biofeedback for affective disorders. Clinical Electroencephalography 2000, 31(1):7-12.
114. Saletu-Zyhlarz G.M., Arnold O., Anderer P., et al. Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping. Alcohol Alcoholism 2004, 39:233-240.
115. SAMHSA (Substance Abuse and Mental Health Services Administration) (2004). Results from the 2003 National Survey on Drug Use and Health (NSDUH Series H-25), Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Rockville, MD.
116. SAMHSA (Substance Abuse and Mental Health Services Administration) (2006). Results from the 2005 National Survey on Drug Use and health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Rockville, MD.
117. Saxby E., Peniston E.G. Alpha-theta brainwave neurofeedback training: an effective treatment for male and female alcoholics with depressive symptoms. Journal of Clinical Psychology 1995, 51(5):685-693.
118. Scott W., Kaiser D. Augmenting chemical dependency treatment with neurofeedback training. Journal of Neurotherapy 1998, 3(1):66.
119. Scott, W. C., Brod, T. M., Sideroff, S., Kaiser, D., and Sagan, M. (2002). Type-specific EEG biofeedback improves residential substance abuse treatment. Paper presented at American Psychiatric Association Annual Meeting 2002.
120. Scott W.C., Kaiser D., Othmer S., Sideroff S.I. Effects of an EEG biofeedback protocol on a mixed substance abusing population. American Journal of Drug Alcohol Abuse 2005, 31(3):455-469.
121. Schubiner H., Tzelepis A., Milberger S., et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry 2000, 61:244-251.
122. Sheehan M.F. Dual diagnosis. Psychiatry Quarterly 1993, 64:107-134.
123. Shufman E., Perl E., Cohen M., et al. Electroencephalography spectral analysis of heroin addicts compared with abstainers and normal controls. Israel Journal of Psychiatry Related Science 1996, 33:196-206.
124. Simon S.L., Domier C., Sim T., Richardson K., Rawson R., Ling W. Cognitive performance of current methamphetamine and cocaine abusers. Journal of Addictive Diseases 2002, 21:61-74.
125. Sokhadze T. Neurofeedback and cognitive behavioral therapy based intervention in dual diagnosis: a neurobiological model. Journal of Neurotherapy 2005, 9(4):123-124.
126. Sokhadze T., Stewart C.M., Hollifield M. Integrating cognitive neuroscience research and cognitive behavioral treatment with neurofeedback therapy in drug addiction comorbid with Post Traumatic Stress Disorder: A conceptual review. Journal of Neurotherapy 2007, 11(2):13-44.
127. Sokhadze, T., Tasman, A., Stewart, C. M., Singh, S., and Hollifield, M. (2007b). Dense-array QEEG/ERP study of frontal deficits in patients with substance use disorder and PTSD. Presented at the 15th Annual Conference of ISNR, San Diego, CA, September 6-9.
128. Sokhadze EM., Cannon R., Trudeau L. EEG biofeedback as a treatment for Substance Use Disorders: review, rating of efficacy, and recommendations for further research. Applied Psychophysiology and Biofeedback. 33(1) 1-28. Journal of Neurotherapy 2008, 12(1):5-43.
129. Struve F.A., Straumanis J.J., Patrick G., Price L. Topographic mapping of quantitative EEG variables in chronic heavy marihuana users: empirical findings with psychiatric patients. Clinical Electroencephalography 1989, 20(1):6-23.
130. Struve F.A., Straumanis J.J., Patrick G. Persistent topographic quantitative EEG sequelae of chronic marihuana use: a replication study and initial discriminant function analysis. Clinical Electroencephalography 1994, 25:63-75.
131. Struve F.A., Patrick G., Straumanis J.J., Fitz-Gerald M.J., Manno J. Possible EEG sequelae of very long duration marihuana use: pilot findings from topographic quantitative EEG analyses of subjects with 15 to 24 years of cumulative daily exposure to THC. Clinical Electroencephalography 1998, 29(1):31-36.
132. Struve F.A., Straumanis J.J., Patrick G., Leavitt J., Manno J., Manno B.R. Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects. Drug and Alcohol Dependence 1999, 56:167-179.
133. Struve F.A., Manno B.R., Kemp P., Patrick G., Manno J. Acute marihuana (THC) exposure produces a "transient" topographic quantitative EEG profile identical to the "persistent" profile seen in chronic heavy users. Clinical Electroencephalography 2003, 34:75-83.
134. Swartz J.A., Lurigio A.J. Psychiatric illness and comorbidity among adult male jail detainees in drug treatment. Psychiatry Service 1999, 50:1628-1630.
135. Tarbox A.R. Alcoholism, biofeedback and internal scanning. Journal Study of Alcohol 1983, 44(2):246-261.
136. Tarter R.E., Kirisci L., Mezzich A., et al. Neurobehavior disinhibition in childhood predicts early age at onset of substance disorder. American Journal of Psychiatry 2003, 160:1078-1085.
137. Triffleman E., Carroll K., Kellogg S. Substance dependence post traumatic stress therapy: an integrated cognitive-behavioral approach. Journal of Substance Abuse Treatment 1999, 17:3-14.
138. Trudeau D.L. A review of the treatment of Addictive Disorders by EEG biofeedback. Clinical Electroencephalography 2000, 31:13-26.
139. Trudeau D.L. EEG Biofeedback for Addictive Disorders - The state of the Art in 2004. Journal of Adult Development 2005, 12:139-146.
140. Trudeau D.L. Applicability of brain wave biofeedback to substance use disorder in adolescents. Child and Adolescent Clinics of North America 2005, 14:125-136.
141. Trudeau D.L., Thuras P., Stockley H. Quantitative EEG findings associated with chronic stimulant and cannabis abuse and ADHD in an adult male substance use disorder population. Clinical Electroencephalography 1999, 30:165-174.
142. Twemlow S.W., Bowen W.T. EEG biofeedback induced self actualization in alcoholics. Journal of Biofeedback 1976, 3:20-25.
143. Twemlow S.W., Bowen W.T. Sociocultural predictors of self actualization in EEG biofeedback treated alcoholics. Psychological Reports 1977, 40:591-598.
144. Twemlow S.W., Sizemore D.G., Bowen W.T. Biofeedback induced energy redistribution in the alcoholic EEG. Journal of Biofeedback 1977, 3:14-19.
145. Venneman S., Leuchter A., Bartzokis G., et al. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. Journal of Neuropsychiatry Clinical Neurosciences 2006, 18(2):208-216.
146. Vernon D.J. Can neurofeedback training enhance performance? An evaluation of the evidence with implication for future research. Applied Psychophysiology and Biofeedback 2005, 30:347-364.
147. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain: insights from imaging studies. Journal of Clinical Investigations 2003, 111:1444-1451.
148. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47:3-13.
149. Watson C.G., Herder J., Passini F.T. Alpha biofeedback therapy in alcoholics: an 18-month follow-up. Journal of Clinical Psychology 1978, 34(3):765-769.
150. Wender P.H. Attention-Deficit Hyperactivity Disorder in Adults 1995, Oxford University Press, New York.
151. Wert R.C., Raulin M.L. The chronic cerebral effects of cannabis use. I. Methodological issues and neurological findings. International Journal of Addiction 1986, 21:605-628.
152. Whitlow C.T., Freedland C.S., Porrino J.L. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat. Psychopharmacology 2002, 161:129-136.
153. Wilens T.E., Biederman J., Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. American Journal of Addictions 1998, 7(2):156-163.
154. Winterer G., Kloeppel B., Heinz A., Ziller M., Dufeu P., Schmidt L.G., Herrmann W.M. Quantitative EEG (QEEG) predicts relapse in patients with chronic alcoholism and points to a frontally pronounced cerebral disturbance. Psychiatry Research 1998, 78:101-113.
155. Winterer G., Enoch M.A., White K., Saylan M., Coppola R., Goldman D. EEG phenotype in alcoholism: increased coherence in the depressive subtype. Acta Psychiatrica Scandinavica 2003, 108:51-60.
156. BR1 gene polymorphism. American Journal of Medical Genetics 2003, 117B:51-56.